| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 12 | 2016 | 106 | 2.010 |
Why?
|
| Spinal Neoplasms | 9 | 2016 | 59 | 1.880 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 7 | 2009 | 63 | 0.710 |
Why?
|
| Schizosaccharomyces pombe Proteins | 5 | 2000 | 36 | 0.660 |
Why?
|
| Schizosaccharomyces | 5 | 2000 | 65 | 0.650 |
Why?
|
| Radiotherapy, Conformal | 5 | 2007 | 55 | 0.630 |
Why?
|
| Spinal Cord Neoplasms | 4 | 2012 | 71 | 0.530 |
Why?
|
| Glioblastoma | 5 | 2007 | 334 | 0.520 |
Why?
|
| Eukaryotic Initiation Factors | 3 | 2000 | 35 | 0.520 |
Why?
|
| Brain Neoplasms | 9 | 2014 | 1243 | 0.510 |
Why?
|
| Disease-Free Survival | 5 | 2012 | 860 | 0.470 |
Why?
|
| Fungal Proteins | 4 | 2000 | 134 | 0.460 |
Why?
|
| Skull Base Neoplasms | 3 | 2011 | 35 | 0.460 |
Why?
|
| Carrier Proteins | 4 | 2014 | 1024 | 0.430 |
Why?
|
| Eukaryotic Initiation Factor-3 | 2 | 2010 | 8 | 0.400 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2012 | 18 | 0.390 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2012 | 21 | 0.380 |
Why?
|
| Spinal Cord Compression | 1 | 2012 | 31 | 0.380 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2011 | 2089 | 0.380 |
Why?
|
| Genes, ras | 1 | 2012 | 98 | 0.380 |
Why?
|
| Chordoma | 2 | 2009 | 20 | 0.380 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2014 | 281 | 0.370 |
Why?
|
| Neoplasm Metastasis | 2 | 2012 | 664 | 0.360 |
Why?
|
| Proton Therapy | 3 | 2009 | 123 | 0.360 |
Why?
|
| Mammary Glands, Human | 1 | 2010 | 80 | 0.340 |
Why?
|
| Spindle Apparatus | 2 | 2000 | 63 | 0.330 |
Why?
|
| ras Proteins | 4 | 2000 | 136 | 0.330 |
Why?
|
| Meningeal Neoplasms | 4 | 2004 | 185 | 0.320 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 266 | 0.320 |
Why?
|
| Saccharomyces cerevisiae | 6 | 1995 | 426 | 0.310 |
Why?
|
| Chondrosarcoma | 1 | 2008 | 11 | 0.300 |
Why?
|
| Cell Cycle Proteins | 4 | 2010 | 646 | 0.290 |
Why?
|
| Online Systems | 1 | 2007 | 13 | 0.280 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 665 | 0.280 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 236 | 0.280 |
Why?
|
| Brain Edema | 1 | 2007 | 69 | 0.270 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 1999 | 92 | 0.260 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2007 | 1126 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2000 | 550 | 0.250 |
Why?
|
| Superoxide Dismutase | 3 | 1991 | 138 | 0.250 |
Why?
|
| Radiotherapy Dosage | 8 | 2016 | 187 | 0.240 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 429 | 0.240 |
Why?
|
| Stereotaxic Techniques | 2 | 2004 | 70 | 0.240 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 6484 | 0.230 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 2505 | 0.220 |
Why?
|
| Middle Aged | 20 | 2020 | 26511 | 0.210 |
Why?
|
| Supine Position | 1 | 2003 | 24 | 0.210 |
Why?
|
| Skull Neoplasms | 1 | 2003 | 14 | 0.210 |
Why?
|
| Radiometry | 1 | 2003 | 38 | 0.210 |
Why?
|
| Aged | 16 | 2019 | 19549 | 0.200 |
Why?
|
| Meningitis | 1 | 2003 | 98 | 0.200 |
Why?
|
| Signal Transduction | 3 | 2014 | 4535 | 0.190 |
Why?
|
| Humans | 41 | 2021 | 124482 | 0.180 |
Why?
|
| Chromosomes, Fungal | 1 | 2000 | 49 | 0.180 |
Why?
|
| Chromosome Segregation | 1 | 2000 | 62 | 0.180 |
Why?
|
| Tobacco Smoking | 1 | 2020 | 19 | 0.180 |
Why?
|
| Social Class | 1 | 2021 | 191 | 0.170 |
Why?
|
| Adult | 18 | 2020 | 29395 | 0.170 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 54 | 0.170 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2003 | 197 | 0.170 |
Why?
|
| Immune System | 1 | 2020 | 87 | 0.170 |
Why?
|
| Phantoms, Imaging | 3 | 2007 | 131 | 0.170 |
Why?
|
| Cortical Bone | 1 | 2019 | 3 | 0.160 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 52 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 3575 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 246 | 0.160 |
Why?
|
| Radiation Injuries | 3 | 2011 | 143 | 0.160 |
Why?
|
| Treatment Failure | 4 | 2007 | 342 | 0.160 |
Why?
|
| Brain | 3 | 2007 | 3004 | 0.160 |
Why?
|
| Palliative Care | 1 | 2003 | 431 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 160 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 368 | 0.150 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2009 | 70 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2012 | 5125 | 0.140 |
Why?
|
| Bone Density | 1 | 2019 | 320 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 487 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2868 | 0.130 |
Why?
|
| Combined Modality Therapy | 6 | 2006 | 1242 | 0.130 |
Why?
|
| Female | 20 | 2019 | 66319 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1995 | 276 | 0.130 |
Why?
|
| Genes, Fungal | 2 | 1995 | 63 | 0.120 |
Why?
|
| Thymosin | 2 | 2005 | 24 | 0.120 |
Why?
|
| Microtubules | 3 | 2000 | 197 | 0.120 |
Why?
|
| Survival Rate | 7 | 2016 | 2028 | 0.120 |
Why?
|
| Molecular Sequence Data | 8 | 2005 | 3875 | 0.120 |
Why?
|
| Male | 19 | 2019 | 61053 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 760 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 198 | 0.110 |
Why?
|
| Methionine | 2 | 1990 | 103 | 0.100 |
Why?
|
| Survival Analysis | 5 | 2007 | 1490 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 321 | 0.100 |
Why?
|
| ErbB Receptors | 2 | 2012 | 284 | 0.100 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2012 | 67 | 0.100 |
Why?
|
| Protein Binding | 2 | 2010 | 1749 | 0.100 |
Why?
|
| Cranial Irradiation | 2 | 2014 | 69 | 0.090 |
Why?
|
| Mastoid | 1 | 2011 | 24 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2012 | 174 | 0.090 |
Why?
|
| Ear, Middle | 1 | 2011 | 25 | 0.090 |
Why?
|
| Disease Progression | 3 | 2007 | 2040 | 0.090 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2010 | 20 | 0.090 |
Why?
|
| Polyribosomes | 1 | 2010 | 25 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 468 | 0.090 |
Why?
|
| F-Box Proteins | 1 | 2010 | 34 | 0.090 |
Why?
|
| Sulfates | 1 | 1990 | 34 | 0.090 |
Why?
|
| Base Sequence | 6 | 2000 | 3097 | 0.080 |
Why?
|
| Pain Management | 1 | 2012 | 181 | 0.080 |
Why?
|
| Ribosomes | 1 | 2010 | 138 | 0.080 |
Why?
|
| Arsenicals | 1 | 1989 | 15 | 0.080 |
Why?
|
| Oxides | 1 | 1989 | 15 | 0.080 |
Why?
|
| Arsenites | 1 | 1989 | 15 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2012 | 459 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2010 | 238 | 0.080 |
Why?
|
| Tubulin | 2 | 2000 | 104 | 0.080 |
Why?
|
| Manganese | 1 | 1989 | 48 | 0.080 |
Why?
|
| Superoxides | 1 | 1989 | 154 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 1990 | 309 | 0.080 |
Why?
|
| Photons | 1 | 2009 | 48 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2004 | 142 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 1989 | 195 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 1898 | 0.080 |
Why?
|
| Arsenic | 1 | 1989 | 46 | 0.080 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2010 | 348 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 355 | 0.070 |
Why?
|
| Epidural Space | 1 | 2007 | 23 | 0.070 |
Why?
|
| Radiation Dosage | 2 | 2007 | 135 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 3338 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2005 | 1460 | 0.070 |
Why?
|
| Survival | 1 | 2007 | 19 | 0.070 |
Why?
|
| Karnofsky Performance Status | 2 | 2004 | 12 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 2004 | 283 | 0.070 |
Why?
|
| Germinoma | 1 | 2006 | 31 | 0.070 |
Why?
|
| Medical Records | 1 | 2007 | 191 | 0.070 |
Why?
|
| Chest Pain | 1 | 2007 | 124 | 0.070 |
Why?
|
| Spine | 1 | 2007 | 143 | 0.070 |
Why?
|
| Prostatic Neoplasms | 2 | 2005 | 1532 | 0.060 |
Why?
|
| Pain | 1 | 2009 | 457 | 0.060 |
Why?
|
| Mutation | 4 | 1999 | 5805 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2016 | 12315 | 0.060 |
Why?
|
| Oxygen | 1 | 1989 | 555 | 0.060 |
Why?
|
| Pelvic Bones | 1 | 2005 | 27 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 582 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 892 | 0.060 |
Why?
|
| Retrospective Studies | 11 | 2011 | 16270 | 0.060 |
Why?
|
| Adolescent | 11 | 2011 | 19301 | 0.060 |
Why?
|
| Linear Models | 1 | 2007 | 672 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2006 | 303 | 0.060 |
Why?
|
| Genetic Complementation Test | 3 | 1994 | 87 | 0.060 |
Why?
|
| Ependymoma | 1 | 2006 | 134 | 0.060 |
Why?
|
| Quality of Life | 1 | 2014 | 1944 | 0.060 |
Why?
|
| Retinoblastoma | 1 | 2005 | 110 | 0.060 |
Why?
|
| Hemangiopericytoma | 1 | 2004 | 10 | 0.060 |
Why?
|
| Retinal Neoplasms | 1 | 2005 | 100 | 0.060 |
Why?
|
| GTP-Binding Proteins | 2 | 1995 | 171 | 0.060 |
Why?
|
| Neoplasms | 2 | 2012 | 2784 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 330 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 818 | 0.050 |
Why?
|
| Decision Trees | 1 | 2003 | 49 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 151 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 88 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2005 | 369 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2005 | 258 | 0.050 |
Why?
|
| Cranial Nerve Diseases | 1 | 2003 | 26 | 0.050 |
Why?
|
| Prognosis | 4 | 2006 | 4572 | 0.050 |
Why?
|
| Eye Neoplasms | 1 | 2003 | 49 | 0.050 |
Why?
|
| Meningioma | 1 | 2004 | 120 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 103 | 0.050 |
Why?
|
| Cerebellar Neoplasms | 1 | 2005 | 285 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 425 | 0.050 |
Why?
|
| Texas | 1 | 2011 | 3588 | 0.050 |
Why?
|
| Medulloblastoma | 1 | 2005 | 340 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2003 | 356 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2004 | 762 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2021 | 64 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 533 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 117 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2021 | 88 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 429 | 0.050 |
Why?
|
| DNA, Fungal | 1 | 2000 | 75 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2020 | 16 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 1999 | 1761 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 185 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2003 | 358 | 0.040 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2020 | 21 | 0.040 |
Why?
|
| Age Factors | 2 | 2006 | 2810 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2005 | 2701 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2011 | 6082 | 0.040 |
Why?
|
| Bronchi | 1 | 2020 | 98 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 1261 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 162 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2000 | 795 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 347 | 0.040 |
Why?
|
| Porosity | 1 | 2019 | 38 | 0.040 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 41 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2021 | 150 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2020 | 209 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 376 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2011 | 228 | 0.040 |
Why?
|
| Tibia | 1 | 2019 | 70 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 295 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 82 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 158 | 0.040 |
Why?
|
| Phenotype | 2 | 2014 | 4258 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2000 | 677 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 862 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 1999 | 329 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 1999 | 392 | 0.040 |
Why?
|
| Kinetics | 2 | 1989 | 1321 | 0.040 |
Why?
|
| Cell Division | 1 | 1999 | 780 | 0.040 |
Why?
|
| Melanoma | 1 | 2004 | 832 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2019 | 264 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1995 | 658 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1236 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2011 | 1017 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2020 | 911 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 1995 | 528 | 0.030 |
Why?
|
| Alleles | 2 | 1991 | 1616 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 1290 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 673 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 1 | 1994 | 2 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2442 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1993 | 157 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 113 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 1994 | 93 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 209 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 229 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 374 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1994 | 212 | 0.030 |
Why?
|
| Salvage Therapy | 2 | 2006 | 194 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 1661 | 0.030 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 1993 | 3 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 710 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1105 | 0.030 |
Why?
|
| Radiography | 2 | 2005 | 827 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 606 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 1992 | 125 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 8970 | 0.020 |
Why?
|
| Meiosis | 1 | 1992 | 115 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 669 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 802 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 1993 | 144 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 374 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1992 | 211 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1994 | 759 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1993 | 226 | 0.020 |
Why?
|
| Child | 6 | 2011 | 24439 | 0.020 |
Why?
|
| RNA, Fungal | 1 | 1991 | 14 | 0.020 |
Why?
|
| Catalase | 1 | 1991 | 50 | 0.020 |
Why?
|
| Otitis Media with Effusion | 1 | 2011 | 18 | 0.020 |
Why?
|
| Organs at Risk | 1 | 2011 | 24 | 0.020 |
Why?
|
| Algorithms | 2 | 2009 | 1614 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 259 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 835 | 0.020 |
Why?
|
| Copper | 1 | 1991 | 63 | 0.020 |
Why?
|
| Oocytes | 1 | 1992 | 284 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2011 | 79 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 1419 | 0.020 |
Why?
|
| Sulfur Oxides | 1 | 1990 | 2 | 0.020 |
Why?
|
| Aerobiosis | 1 | 1990 | 14 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 1990 | 13 | 0.020 |
Why?
|
| Sulfites | 1 | 1990 | 30 | 0.020 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 1990 | 30 | 0.020 |
Why?
|
| Cytosol | 1 | 1990 | 161 | 0.020 |
Why?
|
| Arsenates | 1 | 1989 | 18 | 0.020 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1989 | 22 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1989 | 136 | 0.020 |
Why?
|
| Cognition | 1 | 2014 | 730 | 0.020 |
Why?
|
| Infant | 4 | 2005 | 12473 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1991 | 1108 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2005 | 14043 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2005 | 3269 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1082 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1697 | 0.020 |
Why?
|
| Proteins | 1 | 1993 | 1045 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2303 | 0.020 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2006 | 6 | 0.020 |
Why?
|
| United States | 1 | 2021 | 10821 | 0.020 |
Why?
|
| Electrons | 1 | 2005 | 24 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2006 | 194 | 0.020 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 1703 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2005 | 59 | 0.020 |
Why?
|
| Lectins | 1 | 2005 | 50 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 65 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 238 | 0.010 |
Why?
|
| Adipokines | 1 | 2005 | 60 | 0.010 |
Why?
|
| Models, Biological | 1 | 1990 | 1459 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 293 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2005 | 228 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1991 | 2823 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 256 | 0.010 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2004 | 81 | 0.010 |
Why?
|
| Particle Accelerators | 1 | 2003 | 3 | 0.010 |
Why?
|
| Immobilization | 1 | 2003 | 24 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2005 | 334 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 256 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 764 | 0.010 |
Why?
|
| Genotype | 1 | 1989 | 2551 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 756 | 0.010 |
Why?
|
| Respiration | 1 | 2003 | 120 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 135 | 0.010 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 153 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 775 | 0.010 |
Why?
|
| Movement | 1 | 2003 | 170 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 621 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1392 | 0.010 |
Why?
|
| Equipment Design | 1 | 2003 | 599 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 1423 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1993 | 625 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1686 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 2034 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 2127 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 1327 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 784 | 0.010 |
Why?
|
| Animals | 3 | 2014 | 34157 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 17736 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 1995 | 31 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1995 | 163 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 1995 | 48 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1995 | 145 | 0.010 |
Why?
|
| p21-Activated Kinases | 1 | 1995 | 58 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 162 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 660 | 0.010 |
Why?
|
| Mammals | 1 | 1995 | 260 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1993 | 15 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1993 | 17 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1992 | 23 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1992 | 43 | 0.010 |
Why?
|
| Microinjections | 1 | 1992 | 52 | 0.010 |
Why?
|
| Neurofibromin 1 | 1 | 1993 | 42 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 1993 | 85 | 0.010 |
Why?
|
| Tyrosine | 1 | 1992 | 151 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1995 | 554 | 0.010 |
Why?
|
| Cyclins | 1 | 1992 | 101 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1992 | 113 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 3066 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2004 | 8180 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1992 | 767 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 1583 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1993 | 940 | 0.000 |
Why?
|